Chat with us, powered by LiveChat

Infectious Disease Diagnostic Market (Product - Instruments, Reagents, and Software & Services; Technology - Conventional Technology, Biochemical Technology, and Molecular Technology; Application - Bacterial Infection, Viral Infection, CNS Infection, Cardiovascular Infection, Fungal Infection, Sexually Transmitted Disease, and Other Applications; End Users - Hospital, and Research Institutes): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025

Infectious Disease Diagnostic Market (Product - Instruments, Reagents, and Software & Services; Technology - Conventional Technology, Biochemical Technology, and Molecular Technology; Application - Bacterial Infection, Viral Infection, CNS Infection, Cardiovascular Infection, Fungal Infection, Sexually Transmitted Disease, and Other Applications; End Users - Hospital, and Research Institutes): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025

Report Code: HC0495 Category: Healthcare & Medical Devices Published: May, 2019

A recent report published by Infinium Global Research on infectious disease diagnostic market provides in-depth analysis of segments and sub-segments in the global as well as regional infectious disease diagnostic market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional infectious disease diagnostic market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global infectious disease diagnostics market. According to the report, the global infectious disease diagnostic market is projected to grow at a CAGR of 8.7% over the forecast period of 2019-2025.

 

Market Insight

Infectious disease diagnostics is the procedure by which the causative agent of an infectious disease is identified and often characterized. Infectious disease is one of the common medical condition that accounts for millions of deaths each year. The several types of bacteria, viruses, fungi or parasites are organisms that cause infectious disorders including tuberculosis, malaria, AIDS, and others. It can be based solely on clinical presentation or more rigorous diagnostic tests, such as culturing of the infectious agent, microscopy, biochemical screens, and molecular methods.

 

Increasing incidences of infectious diseases are the key factor that drives the growth of infectious disease diagnosis market. Additionally, increasing demand for advanced technologies in the treatment of infectious disease, and high investment in R&D activities from government and private organizations are fueling the growth of infectious disease diagnostic market. Furthermore, the introduction of point of care diagnosis market to provide high quality, sensitivity, accuracy, and reliability are contributing to the growth of infectious diseases diagnostics market. However, lack of awareness of novel diagnostic technologies, the cost associated with the IDD treatment and stringent government regulatory guidelines are the prime factors restraining the growth of this growth. Moreover, companies operating in the market, which is focusing on developing novel diagnostics, as well as initiatives are taken by the government and private organizations pertaining to the diagnosis of the infectious diseases among the people provide more opportunities for the market to grow over the forecast period.

 

Among the geographies, North America holds the maximum market share in the infectious disease diagnostic market followed by Europe. The growing occurrence of infectious diseases and rising the shift towards decentralized laboratories are the primary factors that drive the growth of North America infectious diseases market. Addition developed healthcare infrastructure and ongoing research on Infectious disease diagnostics are favoring the growth of Infectious disease diagnostics market in the North America region. Furthermore, Asia Pacific is the fastest growing region in the Infectious disease diagnostics market majorly owing to the growing awareness about the Infectious disease and their diagnostics and rising healthcare expenditure.


Global Infectious Disease Diagnostic Market

 

Segment Covered

The report on global infectious disease diagnostic market covers segments such as product, technology, application, and end users. On the basis of product, the sub-markets include instruments, reagents, and software & services. On the basis of technology, the sub-markets include conventional technology, biochemical technology, and molecular technology. On the basis of application, the sub-markets include bacterial infection, viral infection, CNS infection, cardiovascular infection, fungal infection, sexually transmitted disease, and other applications. On the basis of end users, the sub-markets include hospital and research institutes.

 

Companies Profiled:

The report provides profiles of the companies in the market such as Beckman Coulter, Inc., Chembio Diagnostic Systems, Inc., Orasure Technologies, Bio-Rad Laboratories, Inc., BioMérieux, Hologic, Inc., Danaher Corporation, Quidel Corporation, Trinity Biotech plcMeridian Bioscience Inc., and other companies.

 

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of infectious disease diagnostic market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.


CHOOSE LICENCE TYPE

Please Choose One of them.

© 2024. Infinium Global Research LLP. All Rights Reserved.